Musi waMarch 12th 2022, theNMPA (SFDA) yakapa chiziviso ichibvumidza shanduko yechikumbiro chekuzviongorora wega kweCCIDID-19 antigen zvigadzirwa naNanjing Vazyme Biotech.Co., Ltd, Beijing Jinwofu Bioengineering TechnologyCo., Ltd, Shenzhen Huada Yinyuan Pharmaceutical Technology Co., Ltd, Iyo kambani Guangzhou Wondfo Biotech Co., Ltd uyeBEijing Savant Biotechnology Co., Ltd(Huaketai).Zvigadzirwa zvishanu zveCOVID-19 antigen zvekuzviongorora zvakatangwa.
Musi waKurume 11, 2022, NHC yakanga yazivisa kuti, kuitira kuti iwedzere kuvandudza nzira yekuyedza yeNovel Coronavirus uye nekushandira zvinodikanwa zvekudzivirira nekutonga kweCCIDID-19, Chikwata Chakazara cheJoint kudzivirira nekudzora nzira yeHurumende Council yakafunga kuwedzera. antigen kuyedza kune nucleic acid yekuyedza uye yakaita "iyo Yekushandisa Protocol yeNovel Coronavirus Antigen Detection (Trial)"
Iyo protocol inotsanangura huwandu hunoshanda hwekuongororwa kweantigen:
Kutanga, avo vanoshanyira masangano ekurapa ekutanga uye vane zviratidzo zvakaita sekufema turakiti uye fivha mukati memazuva mashanu ekutanga kwezviratidzo;
Chechipiri, vashandi vekutarisa vega, kusanganisira kuvharirwa pamba, kuonana kwepedyo uye kushamwaridzana-pedyo, kuvharirwa kwekutarisa, nzvimbo yekuchengetera uye yekudzora nzvimbo yevashandi;
Yechitatu ndeye vagari venharaunda vane kudiwa kweantigen self-detection.
Mazano:Kuonekwa kweAntigen chinhu chakakosha chekuwedzera kweiyo nucleic acid yekuona, asi mhedzisiro yeantigen self-detection haigone kushandiswa sehwaro hwekuongororwa kwehutachiona.
Nguva yekutumira: Mar-22-2022